These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8815002)

  • 41. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells.
    Takahashi K; Eto H; Tanabe KK
    Int J Cancer; 1999 Jan; 80(3):387-95. PubMed ID: 9935179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction.
    Banerji S; Wright AJ; Noble M; Mahoney DJ; Campbell ID; Day AJ; Jackson DG
    Nat Struct Mol Biol; 2007 Mar; 14(3):234-9. PubMed ID: 17293874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chimeric CD4/CD44 molecules associate with CD44 via the transmembrane region and reduce hyaluronan binding in T cell lines.
    Li R; Walker JR; Johnson P
    Eur J Immunol; 1998 Jun; 28(6):1745-54. PubMed ID: 9645355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The CD44 proteins in embryonic development and in cancer.
    Sherman L; Sleeman J; Dall P; Hekele A; Moll J; Ponta H; Herrlich P
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():249-69. PubMed ID: 8814991
    [No Abstract]   [Full Text] [Related]  

  • 46. Does soluble CD44 reflect the clinical behavior of human cancer?
    Ristamäki R; Joensuu H; Jalkanen S
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():155-66. PubMed ID: 8815003
    [No Abstract]   [Full Text] [Related]  

  • 47. MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.
    Zuo J; Zhu K; Wang Y; Yu Z
    Mol Cell Biochem; 2018 Jun; 443(1-2):139-149. PubMed ID: 29094237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site.
    Kellett-Clarke H; Stegmann M; Barclay AN; Metcalfe C
    PLoS One; 2015; 10(9):e0138137. PubMed ID: 26379032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides.
    Tammi R; MacCallum D; Hascall VC; Pienimäki JP; Hyttinen M; Tammi M
    J Biol Chem; 1998 Oct; 273(44):28878-88. PubMed ID: 9786890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44.
    Teriete P; Banerji S; Noble M; Blundell CD; Wright AJ; Pickford AR; Lowe E; Mahoney DJ; Tammi MI; Kahmann JD; Campbell ID; Day AJ; Jackson DG
    Mol Cell; 2004 Feb; 13(4):483-96. PubMed ID: 14992719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD44-mediated hyaluronan binding marks proliferating hematopoietic progenitor cells and promotes bone marrow engraftment.
    Lee-Sayer SSM; Dougan MN; Cooper J; Sanderson L; Dosanjh M; Maxwell CA; Johnson P
    PLoS One; 2018; 13(4):e0196011. PubMed ID: 29684048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients.
    Birzele F; Voss E; Nopora A; Honold K; Heil F; Lohmann S; Verheul H; Le Tourneau C; Delord JP; van Herpen C; Mahalingam D; Coveler AL; Meresse V; Weigand S; Runza V; Cannarile M
    Clin Cancer Res; 2015 Jun; 21(12):2753-62. PubMed ID: 25762343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of hyaluronan and CD44 in cancer and viral infections.
    Heldin P; Kolliopoulos C; Lin CY; Heldin CH
    Cell Signal; 2020 Jan; 65():109427. PubMed ID: 31654718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of tumor growth in vivo by hyaluronan oligomers.
    Zeng C; Toole BP; Kinney SD; Kuo JW; Stamenkovic I
    Int J Cancer; 1998 Jul; 77(3):396-401. PubMed ID: 9663602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure and function of CD44: characteristic molecular features and analysis of the hyaluronan binding site.
    Bajorath J
    Results Probl Cell Differ; 2001; 33():85-103. PubMed ID: 11190680
    [No Abstract]   [Full Text] [Related]  

  • 56. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
    Bennett KL; Modrell B; Greenfield B; Bartolazzi A; Stamenkovic I; Peach R; Jackson DG; Spring F; Aruffo A
    J Cell Biol; 1995 Dec; 131(6 Pt 1):1623-33. PubMed ID: 8522617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD44 Promotes Inflammation and Extracellular Matrix Production During Arteriovenous Fistula Maturation.
    Kuwahara G; Hashimoto T; Tsuneki M; Yamamoto K; Assi R; Foster TR; Hanisch JJ; Bai H; Hu H; Protack CD; Hall MR; Schardt JS; Jay SM; Madri JA; Kodama S; Dardik A
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1147-1156. PubMed ID: 28450292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mode of cell adhesion and migration facilitated by CD44-dependent microtentacles.
    Wolf KJ; Shukla P; Springer K; Lee S; Coombes JD; Choy CJ; Kenny SJ; Xu K; Kumar S
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11432-11443. PubMed ID: 32381732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Forms and functions of CD44.
    Borland G; Ross JA; Guy K
    Immunology; 1998 Feb; 93(2):139-48. PubMed ID: 9616361
    [No Abstract]   [Full Text] [Related]  

  • 60. Differential expression of Hyaluronic Acid Binding Protein 1 (HABP1)/P32/C1QBP during progression of epidermal carcinoma.
    Ghosh I; Chowdhury AR; Rajeswari MR; Datta K
    Mol Cell Biochem; 2004 Dec; 267(1-2):133-9. PubMed ID: 15663194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.